With systematic treatment monitoring and firm and determined management anaemia can successfully be corrected.

• Patients with renal anaemia can be treated effectively with erythropoiesis-stimulating agents (ESAs), which stimulate red blood cell production. They are injected either under the skin or into a vein to make good the deficiency of natural hormone and thus stimulate the bone marrow to produce new red blood cells.
  A new kind of biosynthetic drug differs from conventional epoetin agents by prolonging the activation of red blood cell production. Its advantage is that it can be given less often, which is friendlier for patients on long-term treatment.
  
• Emergency blood transfusions are given for life-threatening anaemia after major blood loss. Transfusion is not free of risk, since it can cause immune reactions or infection. It is a short-term corrective therapy for acute anaemia.